These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16310341)

  • 1. Identification and functional characterization of a novel interleukin 17 receptor: a possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway.
    Li TS; Li XN; Chang ZJ; Fu XY; Liu L
    Cell Signal; 2006 Aug; 18(8):1287-98. PubMed ID: 16310341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts.
    Kanno T; Takahashi T; Tsujisawa T; Ariyoshi W; Nishihara T
    J Cell Biochem; 2007 Aug; 101(5):1266-77. PubMed ID: 17265428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression.
    Yang W; Chen Y; Zhang Y; Wang X; Yang N; Zhu D
    Cancer Res; 2006 Feb; 66(3):1320-6. PubMed ID: 16452185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.
    Kogut MH; Genovese KJ; He H
    Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
    Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
    Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1.
    Donaldson DD; Whitters MJ; Fitz LJ; Neben TY; Finnerty H; Henderson SL; O'Hara RM; Beier DR; Turner KJ; Wood CR; Collins M
    J Immunol; 1998 Sep; 161(5):2317-24. PubMed ID: 9725226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hSef co-localizes and interacts with Ras in the inhibition of Ras/MAPK signaling pathway.
    Ren Y; Cheng L; Rong Z; Li Z; Li Y; Li H; Wang Z; Chang Z
    Biochem Biophys Res Commun; 2006 Sep; 347(4):988-93. PubMed ID: 16859641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of an active form of the interleukin-2/15 receptor beta-chain by insertion of the intracisternal A particle in a radiation-induced mouse thymic lymphoma and its role in tumorigenesis.
    Ukai H; Ishii-Oba H; Ukai-Tadenuma M; Ogiu T; Tsuji H
    Mol Carcinog; 2003 Jun; 37(2):110-9. PubMed ID: 12766910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
    Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
    Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel alternatively spliced interleukin-1 receptor accessory protein mIL-1RAcP687.
    Lu HL; Yang CY; Chen HC; Hung CS; Chiang YC; Ting LP
    Mol Immunol; 2008 Mar; 45(5):1374-84. PubMed ID: 17949817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells.
    He S; Dibas A; Yorio T; Prasanna G
    Exp Biol Med (Maywood); 2007 Mar; 232(3):370-84. PubMed ID: 17327470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
    Easton JB; Royer AR; Middlemas DS
    J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of mouse IL-22 binding protein.
    Wei CC; Ho TW; Liang WG; Chen GY; Chang MS
    Genes Immun; 2003 Apr; 4(3):204-11. PubMed ID: 12700595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained activation of M-Ras induced by nerve growth factor is essential for neuronal differentiation of PC12 cells.
    Sun P; Watanabe H; Takano K; Yokoyama T; Fujisawa J; Endo T
    Genes Cells; 2006 Sep; 11(9):1097-113. PubMed ID: 16923128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy.
    Friday BB; Adjei AA
    Clin Cancer Res; 2008 Jan; 14(2):342-6. PubMed ID: 18223206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
    Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
    Roberts PJ; Der CJ
    Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.